205 related articles for article (PubMed ID: 29855203)
1. Systemic angiopathy and axonopathy in hereditary transthyretin amyloidosis with Ala97Gly (p. Ala117Gly) mutation: a post-mortem analysis.
Koike H; Yasuda T; Nishi R; Ikeda S; Kawagashira Y; Iijima M; Sobue G; Katsuno M
Amyloid; 2018 Jun; 25(2):141-142. PubMed ID: 29855203
[No Abstract] [Full Text] [Related]
2. Common clinicopathological features in late-onset hereditary transthyretin amyloidosis (Ala97Gly, Val94Gly and Val30Met).
Koike H; Nakamura T; Nishi R; Ikeda S; Kawagashira Y; Iijima M; Yasuda T; Mukai E; Date Y; Shiomi K; Nakazato M; Katsuno M; Sobue G
Amyloid; 2019; 26(sup1):24-25. PubMed ID: 31343348
[No Abstract] [Full Text] [Related]
3. Clinicopathological features of senile systemic amyloidosis: an ante- and post-mortem study.
Ueda M; Horibata Y; Shono M; Misumi Y; Oshima T; Su Y; Tasaki M; Shinriki S; Kawahara S; Jono H; Obayashi K; Ogawa H; Ando Y
Mod Pathol; 2011 Dec; 24(12):1533-44. PubMed ID: 21822203
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic pitfalls in sporadic transthyretin familial amyloid polyneuropathy (TTR-FAP).
Ikeda K; Kano O; Ito H; Kawase Y; Iwamoto K; Sato R; Sekine T; Nagata R; Nakamura Y; Hirayama T; Iwasaki Y
Neurology; 2008 Apr; 70(17):1576; author reply 1576-7. PubMed ID: 18427077
[No Abstract] [Full Text] [Related]
5. Cardiac Involvement in a Patient Cohort With Val30Met Mutation Transthyretin Amyloidosis.
Ripoll-Vera T; Buades J; Cisneros E; Gómez Y; Núñez J; Raya M
Rev Esp Cardiol (Engl Ed); 2019 Jan; 72(1):92-94. PubMed ID: 29223374
[No Abstract] [Full Text] [Related]
6. Ocular manifestations in hereditary transthyretin Gly67Glu amyloidosis.
Leung KCP; Ko TCS
Amyloid; 2019 Sep; 26(3):171-172. PubMed ID: 31135236
[No Abstract] [Full Text] [Related]
7. Evolution of amyloid fibrils in hereditary transthyretin amyloidosis: an ultrastructural study.
Koike H; Nishi R; Ikeda S; Kawagashira Y; Iijima M; Katsuno M; Sobue G
Amyloid; 2019; 26(sup1):26. PubMed ID: 31343346
[No Abstract] [Full Text] [Related]
8. Ophthalmological manifestations in hereditary transthyretin (ATTR V30M) carriers: a review of 513 cases.
Beirão JM; Malheiro J; Lemos C; Beirão I; Costa P; Torres P
Amyloid; 2015; 22(2):117-22. PubMed ID: 26096568
[TBL] [Abstract][Full Text] [Related]
9. Familial amyloidotic polyneuropathy and transthyretin.
Nagasaka T
Subcell Biochem; 2012; 65():565-607. PubMed ID: 23225017
[TBL] [Abstract][Full Text] [Related]
10. Wild-type transthyretin significantly contributes to the formation of amyloid fibrils in familial amyloid polyneuropathy patients with amyloidogenic transthyretin Val30Met.
Tsuchiya-Suzuki A; Yazaki M; Kametani F; Sekijima Y; Ikeda S
Hum Pathol; 2011 Feb; 42(2):236-43. PubMed ID: 21056899
[TBL] [Abstract][Full Text] [Related]
11. A case of transthyretin amyloidosis with myopathy, neuropathy, and cardiomyopathy resulting from an exceedingly rare mutation transthyretin Ala120Ser (c.418G > T, p.Ala140Ser).
Patel K; Tagoe C; Bieri P; Weidenheim K; Tauras JM
Amyloid; 2018 Sep; 25(3):211-212. PubMed ID: 30039724
[No Abstract] [Full Text] [Related]
12. Effects of liver transplantation and tafamidis in hereditary transthyretin amyloidosis caused by transthyretin Leu55Pro mutation: a case report.
Kon T; Misumi Y; Nishijima H; Honda M; Suzuki C; Baba M; Inomata Y; Obayashi K; Ando Y; Tomiyama M
Amyloid; 2015; 22(3):203-4. PubMed ID: 26123280
[No Abstract] [Full Text] [Related]
13. Cryo-EM structure of a transthyretin-derived amyloid fibril from a patient with hereditary ATTR amyloidosis.
Schmidt M; Wiese S; Adak V; Engler J; Agarwal S; Fritz G; Westermark P; Zacharias M; Fändrich M
Nat Commun; 2019 Nov; 10(1):5008. PubMed ID: 31676763
[TBL] [Abstract][Full Text] [Related]
14. [An autopsy case of leptomeningeal amyloidosis associated with transthyretin Gly47Arg mutation].
Uehara T; Kakuda K; Sumi-Akamaru H; Yamauchi A; Mochizuki H; Naka T
Rinsho Shinkeigaku; 2016 Nov; 56(11):777-780. PubMed ID: 27784877
[TBL] [Abstract][Full Text] [Related]
15. Transthyretin amyloidosis: a little history of hereditary amyloidosis.
Benson MD
Amyloid; 2017 Mar; 24(sup1):76-77. PubMed ID: 28434305
[No Abstract] [Full Text] [Related]
16. The challenging histological diagnosis of transthyretin (ATTR) amyloidosis.
Charkhkar E; Westermark P
Amyloid; 2017 Mar; 24(sup1):130-131. PubMed ID: 28434352
[No Abstract] [Full Text] [Related]
17. Amyloidotic breast nodule in hereditary transthyretin amyloidosis (hATTR): a case report.
Cisneros-Barroso E; Losada-López I; González-Moreno J; Buades J; Ferrer-Nadal A; Ripoll-Vera T; Usón M; Figuerola A; Montalà JC; Descals C; Salva-Ramonell F; Torres-Rovira J; Gene-Heym A; Fernández-Burgos I; Soler T
Amyloid; 2019; 26(sup1):59-60. PubMed ID: 31343326
[No Abstract] [Full Text] [Related]
18. Hereditary transthyretin amyloidosis associated with a transthyretin variant Thr59Arg.
Watanabe T; Obayashi K; Misumi Y; Tasaki M; Shinriki S; Ando T; Akagami T; Ueda M; Yamashita T; Hirotani S; Ando Y
Amyloid; 2017 Mar; 24(sup1):119. PubMed ID: 28434332
[No Abstract] [Full Text] [Related]
19. Evidence that glial cells attenuate G47R transthyretin accumulation in the central nervous system.
Sumi-Akamaru H; Eto M; Yamauchi A; Uehara T; Kakuda K; Obayashi K; Kato S; Naka T; Mochizuki H
Neuropathology; 2018 Feb; 38(1):11-21. PubMed ID: 28960480
[TBL] [Abstract][Full Text] [Related]
20. The Swedish open-label diflunisal trial (DFNS01) on hereditary transthyretin amyloidosis and the impact of amyloid fibril composition.
Wixner J; Westermark P; Ihse E; Pilebro B; Lundgren HE; Anan I
Amyloid; 2019; 26(sup1):39-40. PubMed ID: 31343354
[No Abstract] [Full Text] [Related]
[Next] [New Search]
